{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ACH/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T14:00:49.573Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10653,"canonical_name":"ACCENDRA HEALTH INC/VA/","cik":"0000075252","uei":null,"lei":null,"duns":null,"ticker":"ACH"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-10-09","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-115043","accession_number":"0001104659-26-115043","importance":35},{"ts":"2026-09-28","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — ACCENDRA HEALTH INC/VA/ — 2026-09-28","url_slug":"/sec/cik-0000075252/8-k-a/0001104659-26-111408","accession_number":"0001104659-26-111408","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-09-17","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-108405","accession_number":"0001104659-26-108405","importance":35},{"ts":"2026-09-11","kind":"sec.form144","reporter":"Coliseum Capital Management, LLC","title":"10% Stockholder","shares":null,"usd_value":null,"security_title":null,"approx_sale_date":null,"accession_number":"0001193125-26-389327","importance":40},{"ts":"2026-08-17","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-08-17","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-097517","accession_number":"0001104659-26-097517","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ACCENDRA HEALTH INC/VA/ — 2026-08-10","url_slug":"/sec/cik-0000075252/10-q/0001104659-26-093177","accession_number":"0001104659-26-093177","importance":45},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-08-10","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-092973","accession_number":"0001104659-26-092973","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-08-10","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-092999","accession_number":"0001104659-26-092999","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-08-10","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-093381","accession_number":"0001104659-26-093381","importance":35},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-A12B","title":"8-A12B — ACCENDRA HEALTH INC/VA/ — 2026-08-10","url_slug":"/sec/cik-0000075252/8-a12b/0001104659-26-093401","accession_number":"0001104659-26-093401","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — ACCENDRA HEALTH INC/VA/ — 2026-07-24","url_slug":"/sec/cik-0000075252/effect/9999999995-26-002445","accession_number":"9999999995-26-002445","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"S-3","title":"S-3 — ACCENDRA HEALTH INC/VA/ — 2026-07-15","url_slug":"/sec/cik-0000075252/s-3/0001193125-26-304792","accession_number":"0001193125-26-304792","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-06-25","url_slug":"/sec/cik-0000075252/8-k/0001193125-26-282808","accession_number":"0001193125-26-282808","importance":35},{"ts":"2026-06-15","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-06-15","url_slug":"/sec/cik-0000075252/8-k/0001193125-26-271115","accession_number":"0001193125-26-271115","importance":35},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — Galloway Heath H — 2026-05-20","url_slug":"/sec/cik-0001976274/4/0000075252-26-000038","accession_number":"0000075252-26-000038","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Galloway Heath H — 2026-05-19","url_slug":"/sec/cik-0001976274/4/0000075252-26-000034","accession_number":"0000075252-26-000034","importance":30},{"ts":"2026-05-18","kind":"sec.insider.f","reporter":"Galloway Heath H","title":"EVP,General Counsel & CorpSecy","shares":1822,"price_per_share":2.91,"usd_value":5302,"security_title":"Common Stock","importance":15.00530202},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — ACCENDRA HEALTH INC/VA/ — 2026-05-15","url_slug":"/sec/cik-0000075252/8-k/0001104659-26-061888","accession_number":"0001104659-26-061888","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"S-8","title":"S-8 — ACCENDRA HEALTH INC/VA/ — 2026-05-15","url_slug":"/sec/cik-0000075252/s-8/0001104659-26-061906","accession_number":"0001104659-26-061906","importance":30},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Pesicka Edward A","title":"President & CEO","shares":17692,"price_per_share":3.04,"usd_value":53784,"security_title":"Common Stock","importance":15.05378368},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Bernocchi Perry A","title":"EVP, Chief Operating Officer","shares":7908,"price_per_share":3.04,"usd_value":24040,"security_title":"Common Stock","importance":15.02404032},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Leon Jonathan A","title":"EVP & CFO","shares":1770,"price_per_share":3.04,"usd_value":5381,"security_title":"Common Stock","importance":15.0053808},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Galloway Heath H","title":"EVP,General Counsel & CorpSecy","shares":966,"price_per_share":3.04,"usd_value":2937,"security_title":"Common Stock","importance":15.00293664},{"ts":"2026-05-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ACCENDRA HEALTH INC/VA/ — 2026-05-14","url_slug":"/sec/cik-0000075252/schedule-13g-a/0000884546-26-000223","accession_number":"0000884546-26-000223","importance":30},{"ts":"2026-05-14","kind":"sec.insider.a","reporter":"Beck Mark A","title":null,"shares":31191,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-14","kind":"sec.insider.a","reporter":"Kline Teresa L.","title":null,"shares":31191,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-14","kind":"sec.insider.a","reporter":"Klemash Stephen W","title":null,"shares":31191,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-14","kind":"sec.insider.a","reporter":"Gardner-Smith Kenneth","title":null,"shares":31191,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}